Literature DB >> 21415314

High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study.

Yusuke Sakaguchi1, Tatsuya Shoji, Hiroaki Kawabata, Kakuya Niihata, Akira Suzuki, Tetsuya Kaneko, Noriyuki Okada, Yoshitaka Isaka, Hiromi Rakugi, Yoshiharu Tsubakihara.   

Abstract

BACKGROUND AND OBJECTIVES: Obstructive sleep apnea (OSA) affects one of five adults in the general population. Although a high prevalence of OSA has been reported among dialysis patients, the association between nondialysis chronic kidney disease (CKD) and OSA has not been fully investigated. This cross-sectional study aimed to investigate the prevalence of OSA among nondialysis CKD patients in Japan and the association between renal function and OSA. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Consecutive nondialysis CKD patients hospitalized mainly for CKD educational program, regardless of their sleep complaints, were enrolled. The diagnosis of OSA and its severity were measured using a type 3 portable monitor.
RESULTS: Overall (n=100, 68.0% male, median age 66.5 years, body mass index [BMI] 23.1 kg/m(2), estimated GFR [eGFR] 28.5 ml/min per 1.73 m(2)), 65% were diagnosed as OSA: mild OSA (apnea-hypopnea index [AHI] 5.0 to 14.9) in 32%, moderate OSA (AHI 15.0 to 29.9) in 25%, and severe OSA (AHI ≥ 30.0) in 8%. Multivariate logistic regression analysis revealed that a 10-ml/min per 1.73 m(2) decrease in eGFR was associated with a 42% increased odds of OSA after adjustment for age, BMI, and diabetes mellitus. Moreover, in a generalized linear model, eGFR was inversely correlated with AHI after adjustment for covariates.
CONCLUSIONS: This study demonstrated a high prevalence of OSA among nondialysis CKD patients in Japan and that the increased risk of OSA was significantly associated with decreased GFR among these patients. Further investigations are warranted to determine OSA's direct influence on cardiovascular disease.
Copyright © 2011 by the American Society of Nephrology

Entities:  

Mesh:

Year:  2011        PMID: 21415314      PMCID: PMC3087795          DOI: 10.2215/CJN.08670910

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  31 in total

1.  The predictors of central and obstructive sleep apnoea in haemodialysis patients.

Authors:  Takeshi Tada; Kengo Fukushima Kusano; Aiko Ogawa; Jun Iwasaki; Satoru Sakuragi; Isao Kusano; Seiko Takatsu; Masashi Miyazaki; Tohru Ohe
Journal:  Nephrol Dial Transplant       Date:  2007-02-03       Impact factor: 5.992

2.  Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the Sleep Heart Health Study.

Authors:  Mark L Unruh; Mark H Sanders; Susan Redline; Beth M Piraino; Jason G Umans; Terese C Hammond; Imran Sharief; Naresh M Punjabi; Anne B Newman
Journal:  J Am Soc Nephrol       Date:  2006-11-02       Impact factor: 10.121

3.  High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD).

Authors:  Kunitoshi Iseki; Kazuyo Tohyama; Tsuyoshi Matsumoto; Hiroshi Nakamura
Journal:  Hypertens Res       Date:  2008-02       Impact factor: 3.872

4.  Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease.

Authors:  J Beecroft; J Duffin; A Pierratos; C T Chan; P McFarlane; P J Hanly
Journal:  Eur Respir J       Date:  2006-03-01       Impact factor: 16.671

5.  Validation of a portable monitoring system for the diagnosis of obstructive sleep apnea syndrome.

Authors:  Rogerio Santos-Silva; Denis E Sartori; Viviane Truksinas; Eveli Truksinas; Fabiana F F D Alonso; Sergio Tufik; Lia R A Bittencourt
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

6.  Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine.

Authors:  Nancy A Collop; W McDowell Anderson; Brian Boehlecke; David Claman; Rochelle Goldberg; Daniel J Gottlieb; David Hudgel; Michael Sateia; Richard Schwab
Journal:  J Clin Sleep Med       Date:  2007-12-15       Impact factor: 4.062

7.  Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea.

Authors:  J M Beecroft; V Hoffstein; A Pierratos; C T Chan; P A McFarlane; P J Hanly
Journal:  Eur Respir J       Date:  2007-07-11       Impact factor: 16.671

8.  Renal function and sleep-disordered breathing in older men.

Authors:  Muna T Canales; Li-Yung Lui; Brent C Taylor; Areef Ishani; Reena Mehra; Katie L Stone; Susan Redline; Kristine E Ensrud
Journal:  Nephrol Dial Transplant       Date:  2008-07-20       Impact factor: 5.992

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Sleep-disordered breathing in nondialyzed patients with chronic renal failure.

Authors:  Nikolaos Markou; Maria Kanakaki; Pavlos Myrianthefs; Dimitrios Hadjiyanakos; Dimosthenis Vlassopoulos; Anastasios Damianos; Konstantinos Siamopoulos; Miltiadis Vasiliou; Stavros Konstantopoulos
Journal:  Lung       Date:  2006 Jan-Feb       Impact factor: 3.777

View more
  36 in total

1.  Did Osama bin Laden suffer from sleep disordered breathing?

Authors:  Michael J Howell
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

Review 2.  Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?

Authors:  Aibek E Mirrakhimov
Journal:  Sleep Breath       Date:  2012-08-08       Impact factor: 2.816

Review 3.  Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship?

Authors:  Bisher Abuyassin; Kumar Sharma; Najib T Ayas; Ismail Laher
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

4.  Does sleep apnea damage the kidneys?

Authors:  Kelly Liang; Mark Unruh
Journal:  Sleep       Date:  2015-02-01       Impact factor: 5.849

5.  Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.

Authors:  Reiko Okubo; Masahide Kondo; Shu-ling Hoshi; Kunihiro Yamagata
Journal:  Sleep Breath       Date:  2015-02-03       Impact factor: 2.816

6.  Obstructive sleep apnea as a risk factor for incident end stage renal disease: a nationwide population-based cohort study from Korea.

Authors:  Hong Sang Choi; Ha Yeon Kim; Kyung-Do Han; Jin-Hyung Jung; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2019-08-29       Impact factor: 2.801

Review 7.  Obesity in CKD--what should nephrologists know?

Authors:  Peter Stenvinkel; Carmine Zoccali; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

8.  Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization.

Authors:  Keiichi Sumida; Junichi Hoshino; Tatsuya Suwabe; Takatoshi Kasai; Noriko Hayami; Koki Mise; Masahiro Kawada; Aya Imafuku; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Naoki Sawa; Koji Narui; Kenmei Takaichi; Yoshifumi Ubara
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-30       Impact factor: 8.237

9.  Intrarenal hemodynamic and oxidative stress in patients with obstructive sleep apnea syndrome.

Authors:  L Sardo; P Palange; F Di Mario; B Barbano; A Gigante; M Mordenti; A Steffanina; M Bonini; A Amoroso; F Vaccaro; R Cianci
Journal:  Sleep Breath       Date:  2015-04-01       Impact factor: 2.816

10.  Diagnostic value of screening instruments for identifying obstructive sleep apnea in kidney failure.

Authors:  David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2013-01-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.